Company Data
Arbutus Biopharma Corporation
Ticker
ABUS
Current Price
$4.26 -4.91%
Market Cap
$841.5M
Price Target
Refer to Report
Volume
1.8M
52wk Range
$3.04 - $5.1
Overview
Arbutus Biopharma Corp is a pharmaceutical company. It discovers, develops and commercializes cure for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and also involved in licensing of Lipid nanoparticle technology.